Company / Current Assets
Veracyte, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$488.4M
FY2025
5-year range
$243.1M / $488.4M
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#115 of 165
Health Care
What the data says
At $488M, Veracyte, Inc.'s current assets ranks #115 of 165 in the Health Care sector. Current Assets has increased for 4 consecutive years, from $243M in FY2021 to $488M in FY2025.
Based on SEC 10-K filings.
$488M in FY2025 with a 5-year CAGR of +5.4%.
Improved from $286M to $488M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +25.2%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
#115 of 165 in Health CareTop 70% of 165This company $488.4M Sector average $5.2B
▼
-90.7% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s current assets has grown for 4 consecutive years.
- 5-year CAGR of +5.4%, indicating consistent growth.
- In FY2025, current assets increased 31.2% year-over-year.
- Ranks #115 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $488.4M | +31.2% |
| FY2024 | $372.3M | +30.3% |
| FY2023 | $285.6M | +14.9% |
| FY2022 | $248.6M | +2.3% |
| FY2021 | $243.1M | -35.3% |
| FY2020 | $375.7M | +100.2% |
| FY2019 | $187.7M | +93.6% |
| FY2018 | $97.0M | +79.8% |
| FY2017 | $53.9M | -26.8% |
| FY2016 | $73.6M | +53.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026